Current Issue October 2023
DHSC releases first list of January’s price concessions
The Department of Health and Social Care (DHSC) on Wednesday announced the initial list of drug price concessions for January 2020.
The list of prices,...
NICE recommends olaparib for platinum-sensitive ovarian cancer
The National Institute for Health and Care Excellence (NICE) today recommended olaparib (Lynparza) tablets by AstraZeneca for adults with platinum-sensitive ovarian, fallopian tube or...
‘Pharmacists can play vital role in cancer care’
Community pharmacy teams could play a pivotal role in early diagnosis of cancer, according to Royal Pharmaceutical Society.
In a report entitled 'Utilising community pharmacists...
Steven Hildemann to take over as Ipsen’s chief medical officer
Ipsen on Tuesday announced Dr Steven Hildemann as its new Executive Vice President, Chief Medical Officer, Head of Global Medical Affairs and Pharmacovigilance.
The appointment...
MHRA drug alert for Zapain 30mg/500mg tablets
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for 63 batches of Zapain 30mg/500 tablets...
NHS to receive extra £33.9 billion every year by 2024
The government has announced that the NHS Long Term Plan Funding Bill will enshrine in law an extra £33.9 billion a year by 2024.
The...
NICE approves new combination drug for advanced breast cancer
The National Institute for Health and Care Excellence (NICE) has approved another potentially life-extending drug combination for advanced breast cancer patients.
Palbociclib (Ibrance) by Pfizer...
Alliance Healthcare launches new customer-friendly online portal
Alliance Healthcare today launched a new online portal that provides customers with easy access to its systems and services.
The Alliance Health Care Portal offers...
BREAKING: Pharmacist sentenced to prison for supplying £280K worth drugs on black market
A Dudley-pharmacist has received 28 months in prison sentence at Wolverhampton Crown Court on Monday for illegally supplying Class B and Class C controlled drugs...
RPS launches new post approval service for consultant pharmacists
The Royal Pharmaceutical Society (RPS) today launched a new centralised post approval service for NHS consultant pharmacists in England and Wales.
Outlined in the new...